MARY KATE MURRAY: Open Payments
NPI 1811496144 · ORCHARD PARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$672 in 29 payments from 10 companies in 2025. Trend: 2023 $690 · 2024 $2,324 · 2025 $672
Food & beverage: $672
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $254 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $100 |
| Regeneron Healthcare Solutions, Inc. | 2 | $68 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $57 |
| Janssen Biotech, Inc. | 3 | $43 |
| Lilly USA, LLC | 2 | $40 |
| PFIZER INC. | 2 | $35 |
| Tandem Diabetes Care, Inc. | 1 | $33 |
| Intercept Pharmaceuticals, Inc. | 1 | $26 |
| Gilead Sciences, Inc. | 1 | $17 |
Products named: SKYRIZI, CREON, DUPIXENT, XIFAXAN, ENTYVIO, EOHILIA, TREMFYA, VELSIPITY.
Industry payments across NY — which companies pay providers there.
